Cargando…
P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403040/ http://dx.doi.org/10.1016/S2152-2650(22)00489-X |
| _version_ | 1784773281183694848 |
|---|---|
| author | Sgherza, Nicola Curci, Paola Rizzi, Rita Dell’Olio, Grazia Perfetto, Alberto Battisti, Olga Pizzileo, Nicoletta Strafella, Vanda De Trizio, Giovanni Troiano, Teresa Stefanizzi, Pasquale Tafuri, Silvio Musto, Pellegrino |
| author_facet | Sgherza, Nicola Curci, Paola Rizzi, Rita Dell’Olio, Grazia Perfetto, Alberto Battisti, Olga Pizzileo, Nicoletta Strafella, Vanda De Trizio, Giovanni Troiano, Teresa Stefanizzi, Pasquale Tafuri, Silvio Musto, Pellegrino |
| author_sort | Sgherza, Nicola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9403040 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94030402022-08-25 P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma Sgherza, Nicola Curci, Paola Rizzi, Rita Dell’Olio, Grazia Perfetto, Alberto Battisti, Olga Pizzileo, Nicoletta Strafella, Vanda De Trizio, Giovanni Troiano, Teresa Stefanizzi, Pasquale Tafuri, Silvio Musto, Pellegrino Clin Lymphoma Myeloma Leuk Poster Presentations Elsevier Inc. 2022-08 2022-08-25 /pmc/articles/PMC9403040/ http://dx.doi.org/10.1016/S2152-2650(22)00489-X Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Presentations Sgherza, Nicola Curci, Paola Rizzi, Rita Dell’Olio, Grazia Perfetto, Alberto Battisti, Olga Pizzileo, Nicoletta Strafella, Vanda De Trizio, Giovanni Troiano, Teresa Stefanizzi, Pasquale Tafuri, Silvio Musto, Pellegrino P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma |
| title | P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma |
| title_full | P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma |
| title_fullStr | P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma |
| title_full_unstemmed | P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma |
| title_short | P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma |
| title_sort | p-159: effectiveness of anti-sars-cov-2 vaccine “booster” dose in patients with multiple myeloma |
| topic | Poster Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403040/ http://dx.doi.org/10.1016/S2152-2650(22)00489-X |
| work_keys_str_mv | AT sgherzanicola p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT curcipaola p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT rizzirita p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT delloliograzia p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT perfettoalberto p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT battistiolga p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT pizzileonicoletta p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT strafellavanda p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT detriziogiovanni p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT troianoteresa p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT stefanizzipasquale p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT tafurisilvio p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma AT mustopellegrino p159effectivenessofantisarscov2vaccineboosterdoseinpatientswithmultiplemyeloma |